최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Asian Pacific journal of tropical medicine, v.3 no.6, 2010년, pp.454 - 457
Krishnan, P. (Al Shifa College of Pharmacy, Kizhattur, Perinthalmanna, Kerala. Pin-679325) , Saraswathi, R. , Dilip, C. , Ramarao, N.
Objective: To formulate and evaluate acyclovir microcapsules using bakers yeast. Methods: Acyclovir, pretreated yeast and deionised water were taken at a volumetric ratio of 1:2:4 respectively. This suspension was agitated in a magnetic stirrer at 25oC, 30oC, 35oC, and 40oC for 4 hours. The suspensi...
Journal of Microencapsulation Bishop 15 6 761 1998 10.3109/02652049809008259 Microencapsulation in yeast cells
Indian Journal of Dermatology Venereology Leprology Pandhi 59 71 1993 Oral acyclovir in recurrent genital herpes
J Drug Target Degim 14 1 35 2006 10.1080/10611860600566548 A sustained release dosage form of acyclovir for buccal application: an experimental study in dogs
J Contr Rel Pavelic 106 34 2005 10.1016/j.jconrel.2005.03.032 Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir
Int J Pharm Granero 317 1 14 2006 10.1016/j.ijpharm.2006.01.050 Stability of valacyclovir: implications for its oral bioavailability
J Pharm Pharamacol Genta 49 8 737 1997 10.1111/j.2042-7158.1997.tb06103.x Bioadhesive microspheres for ophthalmic administration of acyclovir
Journal of Microencapsulation Cheu 18 5 559 2001 10.1080/02652040010018155 In vitro modified release of acyclovir from ethyl cellulose microspheres
Drug Dev Ind Pharm Tu 27 7 687 2001 10.1081/DDC-100107325 Formulation and pharmacokinetics studies of acyclovir controlled release capsules
J Pharm Sci Diez-Sales 94 5 1039 2005 10.1002/jps.20317 In vitro percutaneous penetration of acyclovir from solvent systems and carbopol 971-P hydrogels: Ifluence of propylene glycol
Int J Pharm Trottet 304 1-2 63 2005 10.1016/j.ijpharm.2005.07.020 Are all acyclovir cream formulations bioequivalent?
Eur J Drug metabolism Pharmacokinetic Zhang 26 3 145 2001 10.1007/BF03190389 Pharmacokinetics and bioavailability of sustained release and conventional formulation of acyclovir
Int J Pharm Afouna 253 1-2 159 2003 10.1016/S0378-5173(02)00705-6 Effect of azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulation in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice
Int JPharm Coceani 254 197 2003 10.1016/S0378-5173(03)00028-0 Acyclovir permeation through rat skin: mathematical modeling and invitro experiments
J Pharm Sci Fresta 90 288 2001 10.1002/1520-6017(200103)90:3 3.0.CO;2-5 Ocular tolerability and in vivo bioavailability of poly (ethylene glycol) (PEG)-coated poly ethyl-2-Cyanoacrylate nanosphere-encapsulated acyclovir
J Contr Rel Law 63 1-2 135 2000 10.1016/S0168-3659(99)00192-3 Acyclovir containing liposomes for potential ocular delivery. Corneal penetration and absorption
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.